ASIA DESLATTES: Open Payments
NPI 1174096721 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 28 payments from 11 companies in 2025. Trend: 2023 $247 · 2024 $369 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $177 |
| Biogen, Inc. | 5 | $139 |
| Exeltis, USA Inc. | 5 | $85 |
| SHIELD THERAPEUTICS INC | 3 | $53 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $35 |
| Boston Scientific Corporation | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Organon LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| OptumHealth Care Solutions, LLC | 1 | $15 |
Products named: Veozah, ZURZUVAE, SLYND, ACCRUFER, General - Female SUI, MYFEMBREE, JADA SYSTEM, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
